CN Stock MarketDetailed Quotes

002932 Wuhan Easy Diagnosis Biomedicine

Watchlist
  • 19.96
  • -0.39-1.92%
Not Open May 15 15:00 CST
4.64BMarket Cap146.76P/E (TTM)

Wuhan Easy Diagnosis Biomedicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-83.63%60.96M
-92.88%749.54M
-91.62%625.93M
-89.77%537.56M
-85.03%372.4M
272.12%10.53B
285.38%7.47B
360.27%5.25B
267.41%2.49B
195.05%2.83B
Operating revenue
-83.63%60.96M
-92.88%749.54M
-91.62%625.93M
-89.77%537.56M
-85.03%372.4M
272.12%10.53B
285.38%7.47B
360.27%5.25B
267.41%2.49B
195.05%2.83B
Other operating revenue
----
--45.47K
----
--0
----
--0
----
--0
----
--0
Total operating cost
-65.90%104.19M
-83.99%720.15M
-79.34%561.15M
-75.47%453.35M
-59.61%305.5M
301.42%4.5B
285.64%2.72B
329.94%1.85B
223.85%756.38M
176.17%1.12B
Operating cost
-82.51%36.41M
-90.18%342.7M
-85.91%323.72M
-82.69%279.97M
-67.92%208.22M
393.78%3.49B
395.32%2.3B
499.38%1.62B
310.85%649.07M
238.30%707.03M
Operating tax surcharges
-82.98%305.6K
-96.24%2.25M
-93.71%2.64M
-92.69%2.29M
-84.88%1.8M
366.92%59.79M
360.30%41.98M
451.13%31.36M
261.13%11.87M
131.69%12.8M
Operating expense
-47.61%24.08M
-74.28%115.95M
-38.92%115.48M
-34.73%82.1M
-7.09%45.96M
128.05%450.77M
64.88%189.05M
62.31%125.78M
32.42%49.47M
114.06%197.66M
Administration expense
-33.02%18.84M
-20.67%112.64M
26.87%78.33M
37.23%52.31M
47.18%28.13M
86.95%141.98M
42.22%61.74M
29.79%38.12M
36.85%19.11M
141.35%75.95M
Financial expense
77.71%-2.63M
114.87%5.19M
-115.39%-65.66M
-63.32%-35.26M
-505.52%-11.79M
-494.15%-34.94M
-435.73%-30.48M
-1,082.02%-21.59M
-29.28%-1.95M
-125.24%-5.88M
-Interest expense (Financial expense)
----
206.73%10.5M
-38.55%1.18M
84.58%2.46M
----
61.85%3.42M
20.70%1.91M
-8.64%1.33M
-38.17%477.77K
223.16%2.11M
-Interest Income (Financial expense)
----
75.26%-4.39M
-508.99%-71.2M
-351.55%-36.36M
----
-51.70%-17.73M
-44.07%-11.69M
-48.34%-8.05M
-66.26%-3.79M
-139.87%-11.69M
Research and development
-18.09%27.18M
-63.59%141.42M
-31.34%106.63M
26.41%71.93M
15.22%33.18M
192.56%388.36M
97.29%155.31M
15.58%56.91M
28.16%28.8M
89.82%132.74M
Credit Impairment Loss
-352.58%-6.88M
78.40%-79.95M
199.34%71.82M
173.43%43.87M
107.08%2.72M
-1,635.03%-370.09M
-307.06%-72.3M
-476.05%-59.74M
-699.11%-38.48M
-228.15%-21.33M
Asset Impairment Loss
----
100.74%4.75M
--36.33M
----
----
---646.67M
----
----
----
--0
Other net revenue
151.33%77.6M
112.15%115.8M
413.32%154.57M
288.91%86.45M
190.69%30.88M
-8,039.46%-953.31M
-222.06%-49.33M
-368.99%-45.76M
-28.98%-34.04M
-232.64%-11.71M
Fair value change income
----
66.25%4.59M
----
----
----
--2.76M
----
----
----
--0
Invest income
20.82%26.86M
243.25%120.55M
87.02%29.67M
292.16%29.28M
402.51%22.23M
5,116.17%35.12M
869.73%15.86M
7,148.59%7.47M
1,902.43%4.42M
-48.61%673.29K
Net open hedge income
----
----
----
----
----
----
----
----
----
--0
-Including: Investment income associates
----
-31.27%-6.73M
---2.36M
-637.28%-2.36M
----
11.17%-5.13M
----
89.14%-320.55K
----
11.10%-5.78M
Exchange income
----
----
----
----
----
----
----
----
----
--0
Asset deal income
---36.01K
3,062.38%307.82K
---413.2K
---269.11K
----
--9.73K
----
----
----
--0
Other revenue
873.67%57.66M
156.47%65.56M
141.64%17.16M
108.53%13.57M
38,569.24%5.92M
185.75%25.56M
779.25%7.1M
1,177.73%6.51M
106.51%15.31K
-35.50%8.94M
Operating profit
-64.85%34.37M
-97.14%145.19M
-95.34%219.35M
-94.92%170.66M
-94.24%97.78M
199.20%5.08B
286.03%4.71B
378.72%3.36B
306.90%1.7B
201.95%1.7B
Add:Non operating Income
136.34%125.22K
419.64%877.52K
157.28%447.09K
35.78%220.71K
2,196.92%52.98K
992.59%168.87K
--173.78K
--162.55K
114.69%2.31K
-88.20%15.46K
Less:Non operating expense
-80.57%375.62K
71.52%6.18M
134.63%5.6M
113.31%4.21M
1,036,291.40%1.93M
10.15%3.6M
-26.68%2.39M
608.31%1.97M
-96.34%186.56
-42.67%3.27M
Total profit
-64.42%34.12M
-97.24%139.89M
-95.45%214.19M
-95.04%166.67M
-94.35%95.9M
199.57%5.08B
286.88%4.7B
378.65%3.36B
306.92%1.7B
204.39%1.69B
Less:Income tax cost
-58.36%6.01M
-89.84%70.67M
-95.60%31.53M
-95.28%24.67M
-94.60%14.44M
180.73%695.84M
296.31%716.58M
388.79%522.71M
297.77%267.32M
205.73%247.87M
Net profit
-65.49%28.11M
-98.42%69.22M
-95.42%182.66M
-94.99%142M
-94.30%81.46M
202.80%4.38B
285.24%3.99B
376.82%2.84B
308.68%1.43B
204.16%1.45B
Net profit from continuing operation
-65.49%28.11M
-98.42%69.22M
-95.42%182.66M
-94.99%142M
-94.30%81.46M
202.80%4.38B
285.24%3.99B
376.82%2.84B
308.68%1.43B
204.16%1.45B
Net income from discontinuing operating
----
----
----
----
----
----
----
----
----
--0
Less:Minority Profit
-165.68%-3.94M
-103.32%-5.71M
-74.74%37.36M
-60.64%29.43M
-85.15%6.01M
414.17%172.06M
404.35%147.92M
397.36%74.76M
373.96%40.44M
399.44%33.46M
Net profit of parent company owners
-57.52%32.05M
-98.22%74.93M
-96.21%145.3M
-95.92%112.57M
-94.57%75.45M
197.79%4.21B
281.76%3.84B
376.29%2.76B
307.05%1.39B
201.37%1.41B
Earning per share
Basic earning per share
-71.43%0.14
-98.21%0.33
-96.26%0.63
-95.94%0.49
-94.60%0.49
85.53%18.46
134.73%16.83
191.55%12.07
156.21%9.07
99.40%9.95
Diluted earning per share
-70.83%0.14
-98.20%0.33
-96.20%0.63
-95.97%0.48
-94.67%0.48
83.84%18.31
133.85%16.58
195.78%11.92
154.52%9.01
99.60%9.96
Other composite income
3.72M
0
Other composite income of parent company owners
----
----
----
--3.72M
----
----
----
----
----
--0
Other composite income of minority owners
----
----
----
----
----
----
----
----
----
--0
Total composite income
-65.49%28.11M
-98.42%69.22M
-95.42%182.66M
-94.86%145.72M
-94.30%81.46M
202.80%4.38B
285.24%3.99B
376.82%2.84B
308.68%1.43B
204.16%1.45B
Total composite income of parent company owners
-57.52%32.05M
-98.22%74.93M
-96.21%145.3M
-95.79%116.29M
-94.57%75.45M
197.79%4.21B
281.76%3.84B
376.29%2.76B
307.05%1.39B
201.37%1.41B
Total composite income of minority owners
-165.68%-3.94M
-103.32%-5.71M
-74.74%37.36M
-60.64%29.43M
-85.15%6.01M
414.17%172.06M
404.35%147.92M
397.36%74.76M
373.96%40.44M
399.44%33.46M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -83.63%60.96M-92.88%749.54M-91.62%625.93M-89.77%537.56M-85.03%372.4M272.12%10.53B285.38%7.47B360.27%5.25B267.41%2.49B195.05%2.83B
Operating revenue -83.63%60.96M-92.88%749.54M-91.62%625.93M-89.77%537.56M-85.03%372.4M272.12%10.53B285.38%7.47B360.27%5.25B267.41%2.49B195.05%2.83B
Other operating revenue ------45.47K------0------0------0------0
Total operating cost -65.90%104.19M-83.99%720.15M-79.34%561.15M-75.47%453.35M-59.61%305.5M301.42%4.5B285.64%2.72B329.94%1.85B223.85%756.38M176.17%1.12B
Operating cost -82.51%36.41M-90.18%342.7M-85.91%323.72M-82.69%279.97M-67.92%208.22M393.78%3.49B395.32%2.3B499.38%1.62B310.85%649.07M238.30%707.03M
Operating tax surcharges -82.98%305.6K-96.24%2.25M-93.71%2.64M-92.69%2.29M-84.88%1.8M366.92%59.79M360.30%41.98M451.13%31.36M261.13%11.87M131.69%12.8M
Operating expense -47.61%24.08M-74.28%115.95M-38.92%115.48M-34.73%82.1M-7.09%45.96M128.05%450.77M64.88%189.05M62.31%125.78M32.42%49.47M114.06%197.66M
Administration expense -33.02%18.84M-20.67%112.64M26.87%78.33M37.23%52.31M47.18%28.13M86.95%141.98M42.22%61.74M29.79%38.12M36.85%19.11M141.35%75.95M
Financial expense 77.71%-2.63M114.87%5.19M-115.39%-65.66M-63.32%-35.26M-505.52%-11.79M-494.15%-34.94M-435.73%-30.48M-1,082.02%-21.59M-29.28%-1.95M-125.24%-5.88M
-Interest expense (Financial expense) ----206.73%10.5M-38.55%1.18M84.58%2.46M----61.85%3.42M20.70%1.91M-8.64%1.33M-38.17%477.77K223.16%2.11M
-Interest Income (Financial expense) ----75.26%-4.39M-508.99%-71.2M-351.55%-36.36M-----51.70%-17.73M-44.07%-11.69M-48.34%-8.05M-66.26%-3.79M-139.87%-11.69M
Research and development -18.09%27.18M-63.59%141.42M-31.34%106.63M26.41%71.93M15.22%33.18M192.56%388.36M97.29%155.31M15.58%56.91M28.16%28.8M89.82%132.74M
Credit Impairment Loss -352.58%-6.88M78.40%-79.95M199.34%71.82M173.43%43.87M107.08%2.72M-1,635.03%-370.09M-307.06%-72.3M-476.05%-59.74M-699.11%-38.48M-228.15%-21.33M
Asset Impairment Loss ----100.74%4.75M--36.33M-----------646.67M--------------0
Other net revenue 151.33%77.6M112.15%115.8M413.32%154.57M288.91%86.45M190.69%30.88M-8,039.46%-953.31M-222.06%-49.33M-368.99%-45.76M-28.98%-34.04M-232.64%-11.71M
Fair value change income ----66.25%4.59M--------------2.76M--------------0
Invest income 20.82%26.86M243.25%120.55M87.02%29.67M292.16%29.28M402.51%22.23M5,116.17%35.12M869.73%15.86M7,148.59%7.47M1,902.43%4.42M-48.61%673.29K
Net open hedge income --------------------------------------0
-Including: Investment income associates -----31.27%-6.73M---2.36M-637.28%-2.36M----11.17%-5.13M----89.14%-320.55K----11.10%-5.78M
Exchange income --------------------------------------0
Asset deal income ---36.01K3,062.38%307.82K---413.2K---269.11K------9.73K--------------0
Other revenue 873.67%57.66M156.47%65.56M141.64%17.16M108.53%13.57M38,569.24%5.92M185.75%25.56M779.25%7.1M1,177.73%6.51M106.51%15.31K-35.50%8.94M
Operating profit -64.85%34.37M-97.14%145.19M-95.34%219.35M-94.92%170.66M-94.24%97.78M199.20%5.08B286.03%4.71B378.72%3.36B306.90%1.7B201.95%1.7B
Add:Non operating Income 136.34%125.22K419.64%877.52K157.28%447.09K35.78%220.71K2,196.92%52.98K992.59%168.87K--173.78K--162.55K114.69%2.31K-88.20%15.46K
Less:Non operating expense -80.57%375.62K71.52%6.18M134.63%5.6M113.31%4.21M1,036,291.40%1.93M10.15%3.6M-26.68%2.39M608.31%1.97M-96.34%186.56-42.67%3.27M
Total profit -64.42%34.12M-97.24%139.89M-95.45%214.19M-95.04%166.67M-94.35%95.9M199.57%5.08B286.88%4.7B378.65%3.36B306.92%1.7B204.39%1.69B
Less:Income tax cost -58.36%6.01M-89.84%70.67M-95.60%31.53M-95.28%24.67M-94.60%14.44M180.73%695.84M296.31%716.58M388.79%522.71M297.77%267.32M205.73%247.87M
Net profit -65.49%28.11M-98.42%69.22M-95.42%182.66M-94.99%142M-94.30%81.46M202.80%4.38B285.24%3.99B376.82%2.84B308.68%1.43B204.16%1.45B
Net profit from continuing operation -65.49%28.11M-98.42%69.22M-95.42%182.66M-94.99%142M-94.30%81.46M202.80%4.38B285.24%3.99B376.82%2.84B308.68%1.43B204.16%1.45B
Net income from discontinuing operating --------------------------------------0
Less:Minority Profit -165.68%-3.94M-103.32%-5.71M-74.74%37.36M-60.64%29.43M-85.15%6.01M414.17%172.06M404.35%147.92M397.36%74.76M373.96%40.44M399.44%33.46M
Net profit of parent company owners -57.52%32.05M-98.22%74.93M-96.21%145.3M-95.92%112.57M-94.57%75.45M197.79%4.21B281.76%3.84B376.29%2.76B307.05%1.39B201.37%1.41B
Earning per share
Basic earning per share -71.43%0.14-98.21%0.33-96.26%0.63-95.94%0.49-94.60%0.4985.53%18.46134.73%16.83191.55%12.07156.21%9.0799.40%9.95
Diluted earning per share -70.83%0.14-98.20%0.33-96.20%0.63-95.97%0.48-94.67%0.4883.84%18.31133.85%16.58195.78%11.92154.52%9.0199.60%9.96
Other composite income 3.72M0
Other composite income of parent company owners --------------3.72M----------------------0
Other composite income of minority owners --------------------------------------0
Total composite income -65.49%28.11M-98.42%69.22M-95.42%182.66M-94.86%145.72M-94.30%81.46M202.80%4.38B285.24%3.99B376.82%2.84B308.68%1.43B204.16%1.45B
Total composite income of parent company owners -57.52%32.05M-98.22%74.93M-96.21%145.3M-95.79%116.29M-94.57%75.45M197.79%4.21B281.76%3.84B376.29%2.76B307.05%1.39B201.37%1.41B
Total composite income of minority owners -165.68%-3.94M-103.32%-5.71M-74.74%37.36M-60.64%29.43M-85.15%6.01M414.17%172.06M404.35%147.92M397.36%74.76M373.96%40.44M399.44%33.46M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg